Form ARS Larimar Therapeutics, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens
- Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
- Antimony Resources Corp. (ATMY) (ATMYF) (K8J0) Appoints Former Director and Professor of the United States Military Academy as Advisory to the Board of Directors
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
